intoDNA News

Check out news and press releases or download our publications.
Read More

intoDNA News

Check out news and press releases or download our publications.
Read More
Nov 17, 2023

STRIDE validated in human in-vivo samples in collaboration with AstraZeneca

In collaboration with AstraZeneca, intoDNA has validated STRIDE as a groundbreaking tool for quantification of DNA breaks in different types of human clinical samples.
Keep Reading
All news
Nov 17, 2023

STRIDE validated in human in-vivo samples in collaboration with AstraZeneca

Keep Reading
Nov 03, 2023

intoDNA exhibits at SITC 2023, the premier cancer immunotherapy conference

Keep Reading
Jul 11, 2023

intoDNA to participate in the 2nd Annual Targeted Radiopharmaceuticals Summit US (TRP)

Keep Reading
May 18, 2023

intoDNA to exhibit at the BIO International Convention 2023

Keep Reading
Mar 28, 2023

intoDNA to present and exhibit at the American Association for Cancer Research Annual Meeting 2023

Keep Reading
Jul 19, 2022

intoDNA joins the BioInMed initiative gathering key medical biotechnology companies in Poland

Keep Reading
Apr 28, 2022

Magda Kordon as an invited speaker at the DNA Repair/Replication Structures & Cancer Conference

Keep Reading
Mar 25, 2022

STRIDE Workshop at the PARP Meeting in Cold Spring Harbor Lab

Keep Reading
Feb 24, 2022

Magda Kordon, CEO attending the 2022 Gordon Research Conference on DNA Damage, Mutation and Cancer

Keep Reading
Jan 24, 2022

intoDNA to present at the 5th Annual DDR, ATR and PARP Inhibitors Summit

Keep Reading
Dec 20, 2021

intoDNA awarded funding from the Polish Agency for Enterprise Development

Keep Reading
Sep 28, 2021

STRIDE featured in Frontiers by our partners at Universitat Autònoma de Barcelona

Keep Reading
See more articles

Selected Publications

sSTRIDE as a technology platform for the detection and measurement of DNA breaks in various DNA repair pathways (DDR Inhibitors Summit 2024)

Maja Białecka, Karolina Uznańska, Olga Wójcikowska, Kamil Solarczyk, et al.

Read More

Detection of DNA damage using STRIDE as a new PD biomarker in liquid biopsies and FFPE tissue sections

Kamil Solarczyk, Agnieszka Waligórska, Małgorzata Szczygieł, Paul Waring, Gemma Jones, et al.

Read More

LP-284, a small molecule acylfulvene, exerts potent antitumor activity in preclinical non-Hodgkin's lymphoma models and in cells deficient in DNA damage repair

Jianli Zhou, Drew Sturtevant, Cassie Love, Aditya Kulkarni, Kishor Bhatia, et al.

Read More
See All Publications

Stay Updated

We are a fast-paced company, continually improving on our technology, processes and business frontiers.

We look forward to sharing more of our progress in the future.

Stay Updated

We are a fast-paced company, continually improving on our technology, processes and business frontiers.

We look forward to sharing more of our progress in the future.